PublicationsOur mission is to improve the lives of individuals and families facing hereditary cancer.
I've Tested Positive, Now What?
FORCE contributes to and collaborates with investigators who build on scientific knowledge through publication of research findings. Read the below list of publications and presentations that involved FORCE effort and staff.
People with metastatic breast cancer face barriers to finding information and support
Pugh Yi R; Welcsh P; Owens K; Rose D; Dearfield C; Kuhn E; Friedman S. Presented at the San Antonio Breast Cancer Symposium - December 9, 2022.
Identification and management of individuals at risk for hereditary cancer in the Medicare population and beyond
Lisa Schlager, Kelly Owens, PhD, Piri Welcsh, PhD, Presented at the International Society of Nurses in Genetics (ISONG) World Congress, November 2022.
Experiences of genetic counselors in referring young and metastatic breast cancer patients to supportive services: A needs assessment
Boninil K, Clark E, Pugh Yi R, Kuhn E, Klemp J, Rose D, Owens K, Welsh P, Duquette D, Friedman S, Dean M, presented at the NSGC conference, Nashville, 11/16/2022
Results of training on digital health literacy for genetic counseling training programs
Pugh Yi R, Dean M, Welcsh P, Owens K, Rose D, Dearfield C, Kuhn E, Clark E, Friedman S. Presented at the American Public Health Association annual meeting, November 6, 2022.
Caregiving in hereditary cancer: Caregivers’ resource and support needs
Mountcastle, L., Friedman, S., & Koehly, L.M. (2022, November 16-20). [Virtual Poster Presentation]. To be presented at the National Society of Genetic Counselors 41st Annual Conference, Nashville, TN.
An evidence-based practice guideline of the National Society of Genetic Counselors for telehealth genetic counseling
Green, S., Hartzfeld, D., Terry, A. B., Fissell, K., Friedman, S., Paolino, N., Principe, K., Sandbach, J., Trzupek, K., Winheld, S., & Malinowski, J. (2022). Journal of Genetic Counseling. August, 2022.
Quality of life results from OlympiA phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline BRCA1/2 mutations...
Ganz P; Bandos H, Spanic T, Friedman S, Müller V; et. al. Cancer Res (2022) 82 (4_Supplement): GS4-09. February, 2022.
Medicaid expansions: Probing Medicaid’s filling of the cancer genetic testing and screening space
Modell, S.M.; Schlager, L.; Allen, C.G.; Marcus, G. Healthcare 2022, 10, 1066.
Using consistent terms in precision medicine to eliminate patient confusion
Martin N, Friedman S, Saxton C, Yarden R, Lindsey S, Kuhn E, Guglielmino J, et. al. Journal of Clinical Oncology 2020 38:15_suppl, e24164-e24164
Utilization, timing, and outcomes of BRCA genetic testing among women with newly diagnosed breast cancer from a national commercially insured population: The ABOARD study
Armstrong J, Lynch K, PhD2; Virgo K, Schwartz M, Friedman S, Dean M, Sutphen R, et. al. JCO Oncology Practice (ascopubs.org). JCO Oncology Practice 2021 17:2, e226-e235
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study
Filipa Lynce, Ilana Schlam, Xue Geng, Beth N Peshkin, Sue Friedman, Julie Dutil, Claudine Isaacs, Kristi D Graves, et. al. J Genet Couns. 2021; 30: 383– 393.
The impact of germline testing for hereditary cancer postdiagnosis
Owens K, Schlager L, Welcsh PL. Am J Manag Care. 2019 Aug;25(9 Spec No.):SP285-SP287.
Results of a pilot test of effects of an online resource on lay audience understanding of media reports on breast cancer research
Yi, R. H. P., Rezende, L., Dearfield, C. T., Welcsh, P., & Friedman, S. (2019). Health Education Journal, 78(5), 607–617.
Effects of online resource to support laypersons’ understanding of media reports on breast cancer research
Pugh-Yi RH, Rezende, Dearfield CT, Owens KN, Welcsh PL, Friedman SJ. Dec. 8, 2018. San Antonio Breast Cancer Symposium Abstract P6-14-08.
Utilization and outcomes of BRCA genetic testing and counseling in a national commercially insured population: The ABOUT study
Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Sutphen R. , et. al. JAMA Oncol. 2015 Dec;1(9):1251-60.
Development, Implementation, and Evaluation of the eXamining Relevance of Articles to Young Survivors (XRAYS) program to summarize recent research findings for young breast cancer survivors...
Pugh-Yi R, PhD, Rezende L, Kramer K, Schlager L, Huynh J, Friedman S. Presentation at the American Public Health Association National Meeting, November 2015.
XRAYS (eXamining Relevance of Articles to Young Survivors) program survey of information needs and media use by young breast cancer survivors and young women at high-risk for breast cancer
Yi RHP, Rezende LF, Huynh J, Kramer K, Cranmer M, Schlager L, Dearfield CT, Friedman SJ. Health Commun. 2018 Dec;33(12):1525-1530. doi: 10.1080/10410236.2017.1372051. Epub 2017 Sep 28. PMID: 28956616.
XRAYS (eXamining Relevance of Articles to Young Survivors) program survey of information needs and media use by young breast cancer survivors and young women at high risk for breast cancer
Rezende L, Huynh J, Kramer K, Cranmer M, Schlager L, Pugh-Yi R, Friedman S. Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12.
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers
Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH. Gynecol Oncol. 2014 May;133(2):283-6. doi: 10.1016/j.ygyno.2014.02.030. Epub 2014 Feb 28. PMID: 24582866; PMCID: PMC4035022.